EUR 3.8
(0.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.3 Million EUR | -16.67% |
2022 | 9.96 Million EUR | 80.21% |
2021 | 5.53 Million EUR | 63.87% |
2020 | 3.37 Million EUR | 59.64% |
2019 | 2.11 Million EUR | -8.8% |
2018 | 2.31 Million EUR | 0.76% |
2017 | 2.3 Million EUR | 8.86% |
2016 | 2.11 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 11.33 Million EUR | 0.0% |
2023 FY | 8.3 Million EUR | -16.67% |
2023 Q4 | 8.3 Million EUR | 0.0% |
2022 Q2 | 5.49 Million EUR | 0.0% |
2022 Q4 | 9.96 Million EUR | 0.0% |
2022 FY | 9.96 Million EUR | 80.21% |
2021 Q2 | 5.76 Million EUR | 0.0% |
2021 FY | 5.53 Million EUR | 63.87% |
2021 Q4 | 5.53 Million EUR | 0.0% |
2020 Q4 | 3.37 Million EUR | 0.0% |
2020 FY | 3.37 Million EUR | 59.64% |
2020 Q2 | 2.32 Million EUR | 0.0% |
2019 Q4 | 2.11 Million EUR | 0.0% |
2019 Q2 | 2.49 Million EUR | 0.0% |
2019 FY | 2.11 Million EUR | -8.8% |
2018 FY | 2.31 Million EUR | 0.76% |
2018 Q4 | 2.31 Million EUR | 0.0% |
2018 Q2 | 3.3 Million EUR | 0.0% |
2017 FY | 2.3 Million EUR | 8.86% |
2017 Q4 | 2.3 Million EUR | 0.0% |
2016 FY | 2.11 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Biosynex SA | 117.41 Million EUR | 92.927% |
bioMĂ©rieux S.A. | 1.5 Billion EUR | 99.449% |
Eurofins Scientific SE | 6.75 Billion EUR | 99.877% |
Lumibird SA | 207.98 Million EUR | 96.007% |